Repository logo
 

Sex differences in coronary atherosclerotic plaque activity using 18F-sodium fluoride positron emission tomography

Accepted version
Peer-reviewed

Loading...
Thumbnail Image

Change log

Abstract

There are sex differences in the extent, severity, and outcomes of coronary artery disease. We aimed to assess the influence of sex on coronary atherosclerotic plaque activity measured using coronary 18F-sodium fluoride (18F-NaF) positron emission tomography (PET), and to determine whether 18F-NaF PET has prognostic value in both women and men.

Methods In a post-hoc analysis of observational cohort studies of patients with coronary atherosclerosis who had undergone 18F-NaF PET CT angiography, we compared the coronary microcalcification activity (CMA) in women and men.

Results Baseline 18F-NaF PET CT angiography was available in 999 participants (151 (15%) women) with 4282 patient-years of follow-up. Compared to men, women had lower coronary calcium scores (116 [interquartile range, 27–434] versus 205 [51–571] Agatston units; p=0.002) and CMA values (0.0 [0.0-1.12] versus 0.53 [0.0-2.54], p=0.01). Following match- ing for plaque burden by coronary calcium scores and clinical comorbidities, there was no sex-related difference in CMAvalues (0.0 [0.0-1.12] versus 0.0 [0.0-1.23], p=0.21) and similar proportions of women and men had no 18F-NaF uptake(53.0% (n =80) and 48.3% (n=73); p=0.42), or CMA values > 1.56 (21.8% (n=33) and 21.8% (n=33); p=1.00). Over a median follow-up of 4.5 [4.0–6.0] years, myocardial infarction occurred in 6.6% of women (n=10) and 7.8% of men(n=66). Coronary microcalcification activity greater than 0 was associated with a similarly increased risk of myocardial infarction in both women (HR: 3.83; 95% CI:1.10-18.49; p =0.04) and men (HR: 5.29; 95% CI:2.28–12.28; p < 0.001).

Conclusion Although men present with more coronary atherosclerotic plaque than women, increased plaque activity is a strong predictor of future myocardial infarction regardless of sex.

Description

Journal Title

European Journal of Nuclear Medicine and Molecular Imaging

Conference Name

Journal ISSN

1619-7070
1619-7089

Volume Title

Publisher

Springer

Rights and licensing

Except where otherwised noted, this item's license is described as Attribution 4.0 International
Sponsorship
EPSRC (EP/T017961/1)
Engineering and Physical Sciences Research Council (EP/N014588/1)
Medical Research Council (MR/N028015/1)
British Heart Foundation (None)
Medical Research Council (1966157)
British Heart Foundation (None)
Evelyn Trust (unknown)
Wellcome Trust (104492/Z/14/Z)
Academy of Medical Sciences (unknown)
Academy of Medical Sciences (None-SGL001\1016)